TRIM21 and colitis: Additionally, TRIM21 expression was found to be reduced in cancers associated with colitis and to negatively regulate intestinal epithelial carcinogenesis by modulating epithelial cell proliferation, adhesion, tissue remodeling, and angiogenesis as well as pro-inflammatory responses [24].